4D Biomaterials
Developer of 4Degra bioresorbable 3D printing materials for medical implants that naturally resorb as tissue heals
- CEO / Founder
- Phil Smith
- Team Size
- 10-20
- Stage
- Active
- Total Funding
- £5M
- Latest Round
- Series A
- Key Investors
- Oshen Holdings, DSW Ventures, SFC Capital, Boundary Capital
Technology & Products
Key Products
4Degra bioresorbable resin platform for 3D printed orthopedic devices and soft tissue scaffolds
Technological Advantage
Proprietary 4Degra resin technology spun out from leading UK universities with extensive IP
Differentiation
Value Proposition
Bioresorbable implants that gradually erode and are resorbed by metabolic processes as natural tissue regenerates
How They Differentiate
3D printable bioresorbable materials enabling customized patient-specific implants
Market & Competition
Target Customers
Orthopedic device manufacturers, medical implant companies, surgeons, hospitals
Industry Verticals
Medical Devices, Orthopedics, Soft Tissue Repair, Healthcare
Competitors
Traditional titanium implant manufacturers, Bioresorbable material companies
Growth & Milestones
Growth Metrics
Preparing for FDA clearance for first orthopedic application
Major Milestones
University spinout formation (2020), £197k Innovate UK grant, £281k pre-seed, Series A £3.4M (2024)
Notable Customers
Clinical testing with leading orthopedic surgeons